HYPERLIPOPROTEINEMIA AS A RISK FACTOR IN THE GENESIS OF ATHEROSCLEROSIS
Main researcher
: SUČIĆ, MATE (45390) Assistants
BABIĆ, DRAŽEN (136332)
PETRUŠIĆ, ANTE (177883)
SOKOLIĆ, LEA (70913)
Type of research: applied Duration from: 01/01/91. to 12/31/95. Papers on project (total): 25
Papers on project quoted in Current Contents: 9
Institution name: Institut za dijabetes, endokrinologiju i bolesti metabolizma "Vuk Vrhovac", Zagreb (45) Department/Institute: Metabolism Department Address: Dugi dol 4a City: 10000 - Zagreb, Croatia
Communication
Phone: 385 (0) 41 232-222 / 266,203
Fax: 385 (0) 41 231-515
E-mail: BABI]¦INDIJA.IDB.HR
Summary: Hyperlipoproteinemia is close to smoking and elevated blood
pressure, the most important risk factor in the genesis of
atherosclerosis and its complications (coronary heart disease, stroke,
peripheral vascular disease). Lipoprotein particles are not of the same
aterogenecity. In distinction from aterogenic LDL
(low-density-lipoprotein) particle, with its main component apoprotein B
(apo B), HDL (high-density-lipoprotein) particle, with its main component
apoprotein A1 (apo A1), is protective (antiaterogenic). Few years ago,
lipoprotein particle Lp (a) has been discovered. The Lp (a) level strong
correlate with coronary heart disease incidence. Lp (a) consists of
apoprotein (a), apoprotein B and LDL particle. It is thought to be
hereditary determined. Atherosclerosis is also, very frequent diabetes
mellitus complication, and to that purpose besides hyperlipoproteinemia
(primarily hypertriglyceridemia), hyperinsulinemia significantly
contribute, too. Hyperinsulinemia is most often the consequence of
present peripheral insulin resistance. Hyperinsulinemia could cause
hypertriglyceridemia, and hyperlipoproteinemia peripheral insulin
resistance with compensatory hyperinsulinemia, as well. That cycle is
potentialy of importance in the atherosclerosis genesis, particularly in
the sense of hypertriglyceridemia and hyperinsulinemia link with early
blood vessel atherosclerotic alterations. Contemporary, due to pancreatic
beta-cell exhaustion, glucose intolerance could also be developed. It was
planned to investigate possible correlation of a certain apoprotein
groups (apo A1, apo B, apo (a)), as well as Lp (a), with the development
of blood vessel atherosclerotic alterations. The effect of
hyperlipoproteinemia (primarily hypertriglyceridemia) on the development
of insulin resistance and hyperinsulinemia, particularly related to
possible glucose intolerance and diabetes mellitus occurence, was
enquired. The consequence of dietary and/or hypolipemic drug treatment on
lipoprotein levels, insulin resistance and peripheral insulinemia, was
also studied. The effect of arterial hypertension, in the framework of
Syndroma X, on the atherosclerosis development was additionaly
investigated. The level of single lipoprotein particles can be affected
by;nutrition, physical activity and medications. 1. Of 255 subjects with
hyperlipoproteinemia 46 (18%)had hyperlipoproteinemia type 2a (acc.to
Frederickson), 123 (48%) type 2b, 57 (22%) type 4 and 29 (12%) type 5.
The increased apo (a) level had 32 (12,5%) subjects. Apo B correlates
with LDL only in hyperlipoproteinemia 2a, somewhat less in type 2b. The
decrease of apo A1 correlates with decrease of HDL only in type 4. Lp(a)
level does not correlate with apo (a) level - of 32 subjects with
increased apo (a) 6 of them had increased Lp(a). 2. Of 60 subjects with
hyperlipoproteinemia (primary or linked to diabetes) tested with CIGMA
(screening test), and 20 with CLAP technique, a connection of peripheral
resistance to diabetes and hypertriglycerdemia and improvement of
aterogenic lipides particles by application of medications and also
without effect to insulin resistence, is found. 3. Of 62 fertile women
(31 control group and 31 subjects) a seasonal application of single
lipoprotein partices was established (control group), and positive effect
of kinesiologic recreationon decrease of aterogenic and increase of
protective lipoprotein particles. on decrease of aterogenic
Research goals: The investigation was carried out as prospective
program,consisting of two parts: 1) It is believed that apoprotein A1 and
B, better than HDL andLDL particle, determination enable us the assessment
of hyperlipoprotein aterogenicity. Therefore, the levels of apoprotein
A1, B and (a) will be determined in subjects with proven
hyperlipoproteinemia, in attempt to answer on followingquestions: - in
which hyperlipoproteinemia types changes of particular apoproteins are
most frequent; - is there any difference in particular apoprotein levels
in relation to possible hyperlipoproteinemia etiology; - what is the
frequency of apoprotein levels increase in our population (small sample);
- what is the Lp (a) level in subjects with increased apo (a)? 2) In the
subjects with primary hyperlipoproteinemia, as well as in the subjects
with secondary hyperlipoproteinemia related to NIDDM, the impact of
hyperlipoproteinemia, respectively particular lipoprotein fractions, on
insulin resistance will be carried out. The aim of the study is to
investigate: - the type and size of the peripheral insulin resistance in
subjects with primary hyperlipoproteinemia (particularly
hipertriglyceridemia), and posssible correlation with plasma insulin
levels; - the type and size of the peripheral insulin resistance in
hyperlipemic NIDDM patients (secondary hyperlipoproteinemia); - the dietary
and/or drug treatment effect on lipoprotein levels and consequently on
peripheral insulin resistance and plasma insulin levels; - the role of
arterial hypertension as a risk factor for the atherosclerosis development
(particularly coronary disease),in the context of complex metabolic
disturbances syndroma (syndrom X). As many factors can change single
lipoprotein particles levels (nutrition, physical activity, medications and
sim.) in healthy persons, the effect of kinesiologic recreation in healthy
persons. For that purpose fertile healthy women were tested as great
number of works dealed with the influence of physical activity to
lipoprotein level in men and women after menopause. In healthy fertile
women the influence of kinesologic recreation to single lipoprotein
particles level was tested.
COOPERATION - PROJECTS
Name of project
: Acipimox in the treatment of NIDDM patients
with concomitant hyperlipoproteinemia (A multicenter trial) Name of institution: Central-Eastern Europe Metabolic Diseases Study
Group & Farmitalia Carlo Erba, Regional Office Eastern Europe, Vienna Other information about the project.